# GLP-1-Cost-Offset-Analysis
A single-page interactive web application that visualizes the findings of a retrospective claims study on the cost-effectiveness of GLP-1 agonists versus DPP-4 inhibitors in Type 2 Diabetes. The application includes dynamic charts, a budget impact model calculator, and a clear, narrative-driven interface to help healthcare payers and stakeholders.
